High Content Screening Market | Growth, Trends, and Forecast (2019-2024)

Market Snapshot

Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The high content screening market was valued at around USD 600 million and is expected to reach a market value of approximately USD 1.05 billion, by registering a growth rate of 9.8%.

Under the conventional method of toxicity studies, large libraries are screened in search of potential drug candidates. This method is expensive, resource- and time-consuming, and has a low success rate. Consequently, high content screening (HCS) solutions for testing the potential toxicity of chemicals and complex substances are being adopted by pharmaceutical companies to improve in-vitro toxicity testing by reducing the time and cost. The need for cost containment in pharmaceutical R&D, advancements in informatics solutions and imaging instruments, and government funding and venture capital investments across developed markets are the major factors driving the growth of the high-content screening (HCS) market. The increasing number of contract research organizations providing HCS outsourcing services and application of HCS in personalized medicine, present significant growth opportunities in the market.

Scope of the Report

High-content screening (HCS) is a method that is used in biological research and drug discovery to identify substances, such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner. High-content screening includes any method used to analyze whole cells or components of cells with a simultaneous readout of several parameters.

Product

Instruments
	Cell Imaging and Analysis Systems
	Flow Cytometers

Consumables
	Reagents and Assay Kits
	Microplates
	Other Consumables

Software

Services

Accessories

Application
		Primary and Secondary Screening
		Target Identification and Validation
		Toxicity Studies
		Compound Profiling
		Other Applications

End User
		Pharmaceutical and Biotechnology Companies
		Academic and Government Institutions
		Contract Research Organisation

Geography

North America
	US
	Canada
	Mexico

Europe
	Germany
	UK
	France
	Italy
	Spain
	Rest of Europe

Asia-Pacific
	China
	Japan
	India
	Australia
	South Korea
	Rest of Asia-Pacific

Middle East & Africa
	GCC
	South Africa
	Rest of Middle East & Africa

South America
	Brazil
	Argentina
	Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

On the basis of Product Type, Instrument segment led the global market in 2018

Based on the product segment, the high content screening market is further segmented into instruments, consumables, software, services, and accessories. The market for HCS software is expected to increase with the highest CAGR between 2019 and 2024. Among all high content screening products, the instrument segment occupies the largest share of the market. The large share of this segment is attributed to advances in instrumentation and automation techniques and high prices of HCS instruments.

To understand key trends, Download Sample Report

APAC region is expected to exhibit the highest growth rate

The high content screening market in APAC is expected to increase at the highest CAGR during the forecast period. Factors, such as increasing drug discovery research, government initiatives, growing focus of multinational companies on emerging markets, and developing R&D infrastructure are driving the growth of the HCS market in this region.

To understand geography trends, Download Sample Report

Competitive Landscape

For compound profiling applications, many pharmaceutical companies are partnering with contract research organizations to identify potential candidates for drug discovery. The HCS market is highly competitive in nature. The majority of large global players are based out of the United States and these players have expertise in other biotechnology/medical-technology verticals as well, which helps them in controlling the major market share, through a presence in the allied markets.

Major Players

* Complete list of players covered available in the table of contents below

1. INTRODUCTION
1. 1.1 Study Deliverables
2. 1.2 Study Assumptions
3. 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Need for Cost Containment in Pharmaceutical R&D
  2. 4.2.2 Government Funding and Venture Capital Investments Across Developed Markets
  3. 4.2.3 Advancements in Informatics Solutions and Imaging Instruments
3. 4.3 Market Restraints
  1. 4.3.1 Lower Adoption of HCS Instruments Due to Their High Prices
4. 4.4 Porter's Five Forces Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products
  5. 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 Product
  1. 5.1.1 Instruments
    1. 5.1.1.1 Cell Imaging and Analysis Systems
    2. 5.1.1.2 Flow Cytometers
  2. 5.1.2 Consumables
    1. 5.1.2.1 Reagents and Assay Kits
    2. 5.1.2.2 Microplates
    3. 5.1.2.3 Other Consumables
  3. 5.1.3 Software
  4. 5.1.4 Services
  5. 5.1.5 Accessories
2. 5.2 Application
  1. 5.2.1 Primary and Secondary Screening
  2. 5.2.2 Target Identification and Validation
  3. 5.2.3 Toxicity Studies
  4. 5.2.4 Compound Profiling
  5. 5.2.5 Other Applications
3. 5.3 End User
  1. 5.3.1 Pharmaceutical and Biotechnology Companies
  2. 5.3.2 Academic and Government Institutions
  3. 5.3.3 Contract Research Organisation
4. 5.4 Geography
  1. 5.4.1 North America
    1. 5.4.1.1 US
    2. 5.4.1.2 Canada
    3. 5.4.1.3 Mexico
  2. 5.4.2 Europe
    1. 5.4.2.1 Germany
    2. 5.4.2.2 UK
    3. 5.4.2.3 France
    4. 5.4.2.4 Italy
    5. 5.4.2.5 Spain
    6. 5.4.2.6 Rest of Europe
  3. 5.4.3 Asia-Pacific
    1. 5.4.3.1 China
    2. 5.4.3.2 Japan
    3. 5.4.3.3 India
    4. 5.4.3.4 Australia
    5. 5.4.3.5 South Korea
    6. 5.4.3.6 Rest of Asia-Pacific
  4. 5.4.4 Middle East & Africa
    1. 5.4.4.1 GCC
    2. 5.4.4.2 South Africa
    3. 5.4.4.3 Rest of Middle East & Africa
  5. 5.4.5 South America
    1. 5.4.5.1 Brazil
    2. 5.4.5.2 Argentina
    3. 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 GE Healthcare
  2. 6.1.2 Danaher Corporation
  3. 6.1.3 Perkinelmer Inc.
  4. 6.1.4 Thermo Fisher Scientific Inc.
  5. 6.1.5 Becton, Dickinson and Company
  6. 6.1.6 Biotek Instruments Inc.
  7. 6.1.7 Bio-Rad Laboratories Inc.
  8. 6.1.8 Yokogawa Electric Corporation
  9. 6.1.9 Merck Millipore
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments